The results showed that CD8-positive cells in the tumors significantly increased in the treatment group and Ki67-positive cells significantly decreased in the treatment group, suggesting that adavosertib induced the infiltration of CD8-positive T cells into the tumors and suppressed tumor growth. This evidence concerns the gene CD8A and neoplasm.